JAK1 and hepatocellular carcinoma: This study found that TPL not only exerts a significant dose-dependent inhibitory effect on the JAK1/STAT3 signaling pathway but also promotes apoptosis in HCC cells by regulating the Bax/Bcl-2 ratio and activating Caspase-3/9.